Otello Stampacchia - Jun 7, 2024 Form 4 Insider Report for Ikena Oncology, Inc. (IKNA)

Role
Director
Signature
/s/ Mark Manfredi, as Attorney-in-Fact for Otello Stampacchia
Stock symbol
IKNA
Transactions as of
Jun 7, 2024
Transactions value $
$0
Form type
4
Date filed
6/10/2024, 04:15 PM
Previous filing
Jun 13, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IKNA Stock Option (Right to Buy) Award $0 +17.5K $0.00 17.5K Jun 7, 2024 Common Stock 17.5K $1.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest in full upon the earlier of (i) June 7, 2025 or (ii) the date of the next annual meeting; provided, however, that all vesting shall cease if the director resigns from the Board or otherwise ceases to serve as a director.